Incyte
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
3.5% Senior Convertible Note due 2011 121,000 N/A N/A
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
3.5% Senior Convertible Note due 2011 25,000 N/A N/A
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 20,000 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 3,493,000 N/A N/A
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
Common Stock 64 $2.16 $138
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 2,000 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 22,000 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
3.5 % Subordinated Convertible Note due 2011 182,000 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 788,000 N/A N/A
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 8,000 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 66,000 $11.22 $740,454
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
Common Stock 264 $2.14 $565
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
3.5 % Subordinated Convertible Note due 2011 546,000 $11.22 $6,125,574
Purchase
FRIEDMAN PAUL A director
Common Stock 11,160 $2.2 $24,552
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 2,363,000 $11.22 $26,510,497
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
Common Stock 9,524 $2.14 $20,400
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 24,000 $11.22 $269,256
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
Common Stock 98 $2.14 $210
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 1,000 $11.22 $11,219
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
Common Stock 5 $2.16 $11
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
Common Stock 2,199 $2.14 $4,710
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 15,756,000 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
3.5 % Subordinated Convertible Note due 2011 1,818,000 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
Common Stock 7,701 $2.15 $16,588
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
Common Stock 17 $2.15 $37
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
Common Stock 343 $2.15 $739
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 81,000 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
Common Stock 927 $2.15 $1,997
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 4,000 $11.22 $44,876
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
Common Stock 33,364 $2.15 $71,866
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 438,000 N/A N/A
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 3,000 N/A N/A
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 52,000 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 138,000 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
3.5 % Subordinated Convertible Note due 2011 1,145,000 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 4,962,000 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 7,627,000 $11.22 $85,567,313
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 78,000 $11.22 $875,082
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
3.5 % Subordinated Convertible Note due 2011 1,761,000 $11.22 $19,756,659
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 4,000 $11.22 $44,876
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 212,000 $11.22 $2,378,428
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
Common Stock 12 $3.25 $39
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
Common Stock 85 $3.25 $276
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
Common Stock 3 $3.25 $10
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 62,000 N/A N/A
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
3.5% Senior Convertible Note due 2011 104,000 $5.61 $583,440
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
3.5% Senior Convertible Note due 2011 15,196,000 $5.61 $85,249,560
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
Common Stock 284,546 $3.61 $1,026,073
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
3.5% Subordinated Convertible Note due 2011 12,000 N/A N/A
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
3.5% Senior Convertible Note due 2011 4,766,000 $5.61 $26,737,260

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.